Evidence map›Paper›PMID 26178240›Full record

ArticleMicrobial cell factories2015

Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis.

Frédéric Samazan, Bachra Rokbi, Delphine Seguin, Fabienne Telles, Valérie Gautier, Gilbert Richarme, Didier Chevret, Paloma Fernández Varela, Christophe Velours, Isabelle Poquet

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Genetically ModifiedJournal of diabetes research · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Frédéric SamazanINRA, UMR1319 Micalis (Microbiologie de l'Alimentation au service de la Santé), Domaine de Vilvert, 78352, Jouy-en-Josas Cedex, France. Frederic.Samazan@curie.fr.
Bachra RokbiSanofi Pasteur, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy L'Etoile, France. Bachra.Rokbi@sanofipasteur.com.
Delphine SeguinSanofi Pasteur, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy L'Etoile, France. Delphine.Seguin@sanofipasteur.com.
Fabienne TellesSanofi Pasteur, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy L'Etoile, France. Fabienne.Telles@sanofipasteur.com.
Valérie GautierStress molecules, Institut Jacques Monod, Université Paris 7, 15 rue Hélène Brion, 75013, Paris, France. valerie.gautier@univ-paris-diderot.fr.
Gilbert RicharmeStress molecules, Institut Jacques Monod, Université Paris 7, 15 rue Hélène Brion, 75013, Paris, France. richarme@paris7.jussieu.fr.
Didier ChevretINRA, UMR1319 Micalis (Microbiologie de l'Alimentation au service de la Santé), Domaine de Vilvert, 78352, Jouy-en-Josas Cedex, France. didier.chevret@jouy.inra.fr.
Paloma Fernández VarelaCNRS, Avenue de la Terrasse, Bât. 34, 91190, Gif-Sur-Yvette, France. Paloma.Fernandez-Varela@lebs.cnrs-gif.fr.
Christophe VeloursCNRS, Avenue de la Terrasse, Bât. 34, 91190, Gif-Sur-Yvette, France. Christophe.Velours@lebs.cnrs-gif.fr.
Isabelle PoquetINRA, UMR1319 Micalis (Microbiologie de l'Alimentation au service de la Santé), Domaine de Vilvert, 78352, Jouy-en-Josas Cedex, France. isabelle.poquet@jouy.inra.fr.
Centre National de la Recherche Scientifique · FRInstitut Mérieux (France) · FRInstitut National de la Recherche Agronomique · MAUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLactococcus lactis, a lactic acid bacterium traditionally used to ferment milk and manufacture cheeses, is also, in the biotechnology field, an interesting host to produce proteins of medical interest, as it is "Generally Recognized As Safe". Furthermore, as L. lactis naturally secretes only one major endogenous protein (Usp45), the secretion of heterologous proteins in this species facilitates their purification from a protein-poor culture medium. Here, we developed and optimized protein production and secretion in L. lactis to obtain proteins of high quality, both correctly folded and pure to a high extent. As proteins to be produced, we chose the two transmembrane members of the HtrA protease family in Staphylococcus aureus, an important extra-cellular pathogen, as these putative surface-exposed antigens could constitute good targets for vaccine development.

resultsA recombinant ORF encoding a C-terminal, soluble, proteolytically inactive and tagged form of each staphylococcal HtrA protein was cloned into a lactococcal expression-secretion vector. After growth and induction of recombinant gene expression, L. lactis was able to produce and secrete each recombinant rHtrA protein as a stable form that accumulated in the culture medium in similar amounts as the naturally secreted endogenous protein, Usp45. L. lactis growth in fermenters, in particular in a rich optimized medium, led to higher yields for each rHtrA protein. Protein purification from the lactococcal culture medium was easily achieved in one step and allowed recovery of highly pure and stable proteins whose identity was confirmed by mass spectrometry. Although rHtrA proteins were monomeric, they displayed the same secondary structure content, thermal stability and chaperone activity as many other HtrA family members, indicating that they were correctly folded. rHtrA protein immunogenicity was established in mice. The raised polyclonal antibodies allowed studying the expression and subcellular localization of wild type proteins in S. aureus: although both proteins were expressed, only HtrA1 was found to be, as predicted, exposed at the staphylococcal cell surface suggesting that it could be a better candidate for vaccine development.

conclusionsIn this study, an efficient process was developed to produce and secrete putative staphylococcal surface antigens in L. lactis and to purify them to homogeneity in one step from the culture supernatant. This allowed recovering fully folded, stable and pure proteins which constitute promising vaccine candidates to be tested for protection against staphylococcal infection. L. lactis thus proved to be an efficient and competitive cell factory to produce proteins of high quality for medical applications.

Indexed as

AnimalsAntigens, BacterialBacterial ProteinsBacterial VaccinesHumansLactococcus lactisMicePeptide HydrolasesProtein FoldingRecombinant ProteinsStaphylococcal InfectionsStaphylococcus aureusAntigens, BacterialBacterial ProteinsBacterial VaccinesPeptide HydrolasesRecombinant Proteins

Identifiers

PMID26178240
PMCPMC4502909
OpenAlexW1963017213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.